5 studies were found.

1.		Recruiting	Safety and Efficacy of S-8184 in Second Line Treatment of Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium Condition: Urologic Neoplasms
2.		Completed	Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer Condition: Non Small Cell Lung Cancer
3.		Completed	Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma Condition: Colorectal Adenocarcinoma
4.		No longer recruiting	Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer Condition: Ovarian Cancer
5.		Recruiting	TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma (TCC) of the Urothelium Conditions: Bladder Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Carcinoma, Transitional Cell